GSK, Pfizer Agree To End Patent Fight Over RSV Vaccines

British pharmaceutical company GlaxoSmithKline PLC and New York-based Pfizer Inc. on Thursday agreed to end their legal fight over Pfizer's respiratory syncytial virus vaccine Abrysvo that allegedly infringed GSK patents that...

Already a subscriber? Click here to view full article